Studies modeling therapies in OI mice show that anabolic and antiresorptive agents (e.g., BMP-2, bisphosphonates) can modulate fracture healing, but BMP-2 alone is less effective in OI settings [177]. This evidence concerns the gene BMP2 and osteogenesis imperfecta.